BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23152551)

  • 1. Performance evaluation of the new Roche cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, for detection and quantification of hepatitis C virus RNA.
    Pas S; Molenkamp R; Schinkel J; Rebers S; Copra C; Seven-Deniz S; Thamke D; de Knegt RJ; Haagmans BL; Schutten M
    J Clin Microbiol; 2013 Jan; 51(1):238-42. PubMed ID: 23152551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.
    Chevaliez S; Bouvier-Alias M; Rodriguez C; Soulier A; Poveda JD; Pawlotsky JM
    J Clin Microbiol; 2013 Apr; 51(4):1078-82. PubMed ID: 23325825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
    Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
    J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity.
    Vermehren J; Colucci G; Gohl P; Hamdi N; Abdelaziz AI; Karey U; Thamke D; Zitzer H; Zeuzem S; Sarrazin C
    J Clin Microbiol; 2011 Sep; 49(9):3309-15. PubMed ID: 21752967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.
    Vermehren J; Kau A; Gärtner BC; Göbel R; Zeuzem S; Sarrazin C
    J Clin Microbiol; 2008 Dec; 46(12):3880-91. PubMed ID: 18799708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
    Wirden M; Larrouy L; Mahjoub N; Todesco E; Damond F; Delagreverie H; Akhavan S; Charpentier C; Chaix ML; Descamps D; Calvez V; Marcelin AG
    J Clin Virol; 2017 Nov; 96():49-53. PubMed ID: 28950186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
    Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
    Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pierce VM; Eversley JS; Tran TK; Rosenberg ES
    Clin Chem Lab Med; 2017 Jun; 55(7):956-961. PubMed ID: 27988503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 (CAP/CTM v2.0) with other real-time PCR assays in HIV-1 monitoring and follow-up of low-level viral loads.
    Wojewoda CM; Spahlinger T; Harmon ML; Schnellinger B; Li Q; Dejelo C; Schmotzer C; Zhou L
    J Virol Methods; 2013 Jan; 187(1):1-5. PubMed ID: 23098667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
    Pyne MT; Hillyard DR
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.
    Taylor N; Haschke-Becher E; Greil R; Strasser M; Oberkofler H
    Antivir Ther; 2014; 19(5):449-54. PubMed ID: 24430620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
    Sarrazin C; Dragan A; Gärtner BC; Forman MS; Traver S; Zeuzem S; Valsamakis A
    J Clin Virol; 2008 Oct; 43(2):162-8. PubMed ID: 18692434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
    J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay.
    Tuaillon E; Mondain AM; Ottomani L; Roudière L; Perney P; Picot MC; Séguret F; Blanc F; Larrey D; Van de Perre P; Ducos J
    J Clin Microbiol; 2007 Sep; 45(9):3077-81. PubMed ID: 17581929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
    Sarrazin C; Gärtner BC; Sizmann D; Babiel R; Mihm U; Hofmann WP; von Wagner M; Zeuzem S
    J Clin Microbiol; 2006 Mar; 44(3):729-37. PubMed ID: 16517847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA.
    Wolff D; Gerritzen A
    Clin Chem Lab Med; 2007; 45(7):917-22. PubMed ID: 17617038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays.
    Vermehren J; Bourlière M; Pol S; Marcellin P; Hyland RH; Jiang D; Brainard DM; Zeuzem S; Welzel TM
    J Clin Virol; 2017 Apr; 89():51-56. PubMed ID: 28259054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test.
    Pyne MT; Mallory M; Hillyard DR
    J Clin Virol; 2015 Apr; 65():54-7. PubMed ID: 25766989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment.
    Wiesmann F; Naeth G; Berger A; Hirsch HH; Regenass S; Ross RS; Sarrazin C; Wedemeyer H; Knechten H; Braun P
    Med Microbiol Immunol; 2016 Jun; 205(3):263-8. PubMed ID: 26666643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.